Stock Research: Insulet

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Insulet

NSQ:PODD US45784P1012
80
  • Value
    10
  • Growth
    97
  • Safety
    Safety
    35
  • Combined
    45
  • Sentiment
    95
  • 360° View
    360° View
    80
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Insulet Corporation is a medical device company specializing in continuous insulin delivery systems. It operates in the medical device industry, with its primary product being the Omnipod System. The company serves people with insulin-dependent diabetes and also produces pods for Amgen's Neulasta Onpro kit. In the last fiscal year, the company had a market cap of $20,451 million, profits of $1,446 million, revenue of $2,072 million, and 3900 employees.

more
Index
NASDAQ
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 1 4 1
Growth
97 67 71 65
Safety
Safety
35 26 4 16
Sentiment
95 90 90 16
360° View
360° View
80 46 27 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
91 80 64 14
Opinions Change
52 50 64 54
Pro Holdings
n/a 88 85 48
Market Pulse
86 69 74 21
Sentiment
95 90 90 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
10 1 4 1
Growth
97 67 71 65
Safety Safety
35 26 4 16
Combined
45 4 4 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
31 11 18 9
Price vs. Earnings (P/E)
26 9 19 10
Price vs. Book (P/B)
13 8 1 7
Dividend Yield
1 1 1 1
Value
10 1 4 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
80 81 73 45
Profit Growth
83 65 85 70
Capital Growth
83 19 46 69
Stock Returns
59 83 43 61
Growth
97 67 71 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
28 15 6 15
Refinancing
24 23 9 15
Liquidity
81 81 74 72
Safety Safety
35 26 4 16

Similar Stocks

Discover high‑ranked alternatives to Insulet and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: